Davunetide is an eight amino acid snippet derived from activity-dependent neuroprotective protein (ADNP), a neurotrophic factor that exists in the mammalian CNS. Davunetide possesses neuroprotective, neurotrophic and cognitive protective roperties. Davunetide, a microtubule-stabilizing peptide, interacts with and stabilises neuron-specific βIII-tubulin in vitro. Davunetide penetrates the blood-brain barrier and is non-toxic. Davunetide inhibits Aβ aggregation and Aβ-induced neurotoxicity.
性状
Solid
体内研究(In Vivo)
Davunetide (2 μg/kg; Intranasally; daily, 5 days a week, for 16 weeks) shows protective effects for central nervous system complications in a diabetes rat model. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
ClinicalTrial
SequenceShortening
NAPVSIPQ
参考文献
[1]. Quraishe S, et al. NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy. Mol Psychiatry. 2013;18(7):834-842.[2]. Zhang J, et al. Davunetide improves spatial learning and memory in Alzheimers disease-associated rats. Physiol Behav. 2017;174:67-73.[3]. Idan-Feldman A, et al. Davuneti
溶解度数据
In Vitro: DMSO : 125 mg/mL (151.53 mM; Need ultrasonic)H2O : 100 mg/mL (121.22 mM; Need ultrasonic)配制储备液